The enhancement of ER stress with heat shock protein 90 (HSP90) inhibitors coupled with inhibitors of mechanistic target of rapamycin protein (mTOR) led to tumor shrinkage in a genetically engineered murine MPNST model, which correlated with profound ER damage and cell death [43]. The gene discussed is MTOR; the disease is malignant peripheral nerve sheath tumor.